Humana (NYSE:HUM) Stock Price Down 0.2%

Humana Inc. (NYSE:HUM) shares dropped 0.2% on Monday . The company traded as low as $303.39 and last traded at $305.31. Approximately 273,967 shares traded hands during mid-day trading, a decline of 86% from the average daily volume of 1,973,544 shares. The stock had previously closed at $305.90.

Wall Street Analysts Forecast Growth

HUM has been the subject of a number of analyst reports. StockNews.com downgraded shares of Humana from a “strong-buy” rating to a “hold” rating in a research note on Friday, January 26th. Jefferies Financial Group dropped their price target on shares of Humana from $411.00 to $381.00 and set a “buy” rating on the stock in a research report on Monday, April 22nd. Royal Bank of Canada decreased their target price on Humana from $415.00 to $353.00 and set an “outperform” rating for the company in a research report on Thursday, April 25th. Cantor Fitzgerald dropped their price objective on Humana from $391.00 to $360.00 and set a “neutral” rating on the stock in a research note on Thursday, April 25th. Finally, Mizuho lowered their price objective on Humana from $550.00 to $400.00 and set a “buy” rating on the stock in a research note on Friday, January 26th. Eleven equities research analysts have rated the stock with a hold rating and nine have given a buy rating to the stock. Based on data from MarketBeat, Humana currently has an average rating of “Hold” and a consensus target price of $424.50.

Humana Trading Down 0.3 %

The stock has a 50 day moving average of $325.94 and a 200 day moving average of $392.00. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.67 and a quick ratio of 1.67. The firm has a market cap of $36.40 billion, a P/E ratio of 18.81, a PEG ratio of 1.76 and a beta of 0.45.

Humana (NYSE:HUM) last announced its quarterly earnings data on Wednesday, April 24th. The insurance provider reported $7.23 EPS for the quarter, beating the consensus estimate of $6.12 by $1.11. The firm had revenue of $29.61 billion for the quarter, compared to analyst estimates of $28.52 billion. Humana had a return on equity of 17.76% and a net margin of 1.82%. The company’s revenue was up 10.7% on a year-over-year basis. During the same period in the prior year, the company earned $9.38 EPS. As a group, equities research analysts predict that Humana Inc. will post 16.18 EPS for the current year.

Humana Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, July 26th. Investors of record on Friday, June 28th will be issued a dividend of $0.885 per share. This represents a $3.54 annualized dividend and a dividend yield of 1.17%. The ex-dividend date of this dividend is Friday, June 28th. Humana’s dividend payout ratio is currently 22.04%.

Insider Buying and Selling

In related news, Director Jorge S. Mesquita acquired 545 shares of Humana stock in a transaction dated Tuesday, February 20th. The shares were purchased at an average cost of $367.09 per share, with a total value of $200,064.05. Following the completion of the purchase, the director now owns 2,578 shares of the company’s stock, valued at $946,358.02. The transaction was disclosed in a document filed with the SEC, which is available through this link. 0.29% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently made changes to their positions in the company. Diversify Advisory Services LLC purchased a new position in Humana in the first quarter worth about $1,195,000. J.W. Cole Advisors Inc. purchased a new stake in Humana in the first quarter worth about $281,000. Norden Group LLC raised its stake in Humana by 137.9% during the 1st quarter. Norden Group LLC now owns 1,130 shares of the insurance provider’s stock worth $392,000 after acquiring an additional 655 shares during the period. HB Wealth Management LLC lifted its stake in shares of Humana by 7.7% during the 1st quarter. HB Wealth Management LLC now owns 3,243 shares of the insurance provider’s stock valued at $1,124,000 after buying an additional 231 shares in the last quarter. Finally, SpiderRock Advisors LLC bought a new position in shares of Humana in the first quarter worth about $768,000. Hedge funds and other institutional investors own 92.38% of the company’s stock.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.